Result Summary for EPI40404

Result Summary
Protocol ID: EPI40404
Clinical Study ID: EPI40404 (follow-up to EPIP083)
Official Title: EPIDEMIOLOGY STUDY: Paroxetine in the First Trimester and the Prevalence of Congenital Malformations (Follow-up to Epidemiology Study: Final Report on Bupropion and Other Antidepressants, including Paroxetine, in Pregnancy and the Occurrence of Cardiovascular and Major Congenital Malformations)
Phase: Phase 4
Study Indications or Diseases:
  • Depressive Disorder, Major
Generic Name: paroxetine
Trade/Product Name: Aropax,Deroxat,Paxil,Tagonis,Seroxat
Approved Drug Label: http://www.gsk.com/products/index.html
Results Summary: Click here to download result summary. Click here to download result summary.
(143.62KB)
Citations: